Here's the Under-the-Radar Biotech That Could Beat Moderna at Its Own Game

Moderna has deservedly received a lot of attention from the press and from investors. But there's another small biotech quietly working on a COVID-19 vaccine that's using the same approach as Moderna. This under-the-radar biotech just might even beat Moderna at its own game.